NCT06544876 Balance Control and Recovery in Diabetes Peripheral Neuropathy
| NCT ID | NCT06544876 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lisa Griffin |
| Condition | Diabetic Peripheral Neuropathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-09-12 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2023-09-12 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study the effects of diabetic peripheral neuropathy will be assessed on balance control, balance recovery, and muscle electrical activity in adults over 50 years. Aim 1: Determine muscle activity and balance control during a sit-to-stand in adults age above 50 with and without diabetic peripheral neuropathy. Aim 2: Assess local balance recovery and latency responses to lateral surface perturbation during quiet standing.
Eligibility Criteria
Inclusion Criteria: * Type II diabetes with peripheral neuropathy Exclusion Criteria: * Foot ulcer * Partial amputation * Have experience of Stroke * Painful neuropathy * Inability to stand or walk independently
Frequently Asked Questions
Who can join the NCT06544876 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 99 Years, studying Diabetic Peripheral Neuropathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06544876 currently recruiting?
Yes, NCT06544876 is actively recruiting participants. Visit ClinicalTrials.gov or contact Lisa Griffin to inquire about joining.
Where is the NCT06544876 trial being conducted?
This trial is being conducted at Austin, United States.
Who is sponsoring the NCT06544876 clinical trial?
NCT06544876 is sponsored by Lisa Griffin. The trial plans to enroll 60 participants.